Welcome From the Chair

Welcome From The Chair

“It is my pleasure to welcome you to the Department of Pathology and Laboratory Medicine at New York Presbyterian Hospital – Weill Cornell Medical Center, one of the truly excellent pathology departments in the United States. We are fortunate to be based in the Weill Cornell Medical College, a small but prestigious Ivy League medical school, and in New York – Presbyterian Hospital, one of the top ranked hospitals in the United States.

Our mission is to integrate medial science...   [Read the full message from the chair]


Find a Faculty Member

News & Highlights

Residents Research Day
April 19, 2012

Winner for best presentation include Drs. Scherl, Khani and Yan
For details on all presentations click here.
View photos | one | two | three

 

Mark Rubin, MD part of "Dream Team" in Metastatic Prostate Cancer.

"Understanding the mutational landscape of individual tumors will allow us to better manage metastatic prostate cancers like castration-resistant prostate cancer," explains Dr. Mark A. Rubin, the project's principal investigator at Weill Cornell Medical College. The overarching goal of the grant is to eventually "position CRPC as a manageable and treatable disease with personalized medicine."
Read More

 

Researchers Discover Achilles' Heel in Lethal Form of Prostate Cancer

Weill Cornell Physician-Scientists Say This Vulnerability Can Be Attacked by a Targeted Drug Already in Clinical Trials to Treat Other Types of Cancers. Read More

 

Dr. Mark A. Rubin to Provide Insights From Genomic Approaches to Oncology Discovery

Mark A. Rubin, MD, this year’s keynote speaker, is vice chair for experimental research, professor of pathology and laboratory medicine, and the Homer T. Hirst Professor of oncology in pathology at the Weill Cornell Medical College in New York City. Formerly, he was director of genitourinary pathology at the University of Michigan and the Brigham and Women’s Hospital in Boston. Read More

 

Dr. Mark A. Rubin

Whole Genome Sequencing for Prostate Cancer

More DNA Rearrangements Found than Previously Expected. The first study to compare the genomic sequences of multiple prostate tumors has found recurring rearrangements of DNA that may contribute to the development of the disease. Using tumor samples from seven WCMC patients, Dr. Mark A. Rubin (WCMC) and Dr. Levi Garraway of the Dana-Farber Cancer Institute confirmed the existence of previously identified genetic changes associated with prostate cancer and discovered other alterations that could lead to new treatments for the disease. The Team from WCMC, Dana-Farber Cancer Institute, and the Broad Institute of M.I.T. and Harvard reported the findings February 10 in Nature.

 

Weill Cornell Pathologists - "BEST DOCTORS" New York Magazine 2011

Weill Cornell Pathologists listed in New York Magazing "Best Doctors" New York Metro Area. Dr. Attilio Orazi, Professor of Pathology and Laboratory Medicine.

 
 
 
Pathology and Laboratory Medicine Comprehensive Consultation Practice

Prominent among the faculty are several internationally recognized authorities in areas of Hematopathology, Dermatopathology, Surgical Pathology, and Laboratory Medicine.


Building on their expertise, we have developed a nation-wide diagnostic and patient management consultation service in support of our reference laboratory services. [more]

click for Breast brichure click for Dermatopathology brichure click for Hemepath brichure